Topadur Pharma AG

📍 Schlieren, Switzerland🗓 Founded 2015👥 16 employees💰 Last funded May 2026
Biotechnology Research🌐 topadur.com
Website LinkedIn
Topadur Pharma AG is a Swiss biopharmaceutical scale-up based in Schlieren, Zurich. The company was founded in 2015 by experienced scientists that combine several years of expertise in R&D Pharma. Topadur’s vision is to improve patients’ quality of life by providing highly effective and safe drugs for unmet medical conditions. Topadur has discovered and developed new dual-acting drugs that target the cGMP-Enzyme Regulation System to stimulate microcirculation, enable tissue regeneration, and avoid local oxygen deficiency. Based on our key invention we have developed an attractive portfolio of drug candidates to treat aging-related diseases like chronic wounds, skin fibrosis, age-related macular degeneration, colorectal cancer, hair loss and skin aging.
3
Total investors
1
Early stage
0
Mid stage
1
Late stage
2015
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Switzerland
2
Italy
1
Investor activity2017–2026 · investors recorded per year
201712024120261
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Topadur Pharma AG?
Topadur Pharma AG has 3 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did Topadur Pharma AG last raise funding?
The most recent investment in Topadur Pharma AG recorded on gritt.io was in May 2026.
When was Topadur Pharma AG founded?
Topadur Pharma AG was founded in 2015.
What industry is Topadur Pharma AG in?
Topadur Pharma AG operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Topadur Pharma AG based?
Topadur Pharma AG is headquartered in Schlieren, Switzerland.